Brigham and Women's Hospital at AMP 2026

Nov 10–14, 2026 Seattle, WA ~2k attendees Website

Brigham and Women's Hospital brings 4 presentations to AMP 2026 in Seattle. Its sessions centre on haematopathology and solid-tumour molecular testing, including current and emerging methods for finding structural variants and gene fusions. One example is the clinical value of detecting mismatch repair deficiency as a mutational signature.

Organization

AMP 2026 Attendance

Brigham and Women's Hospital

Boston, MA

brighamandwomens.org

Med centres

Harvard-affiliated teaching hospital in Boston with clinical molecular pathology, haematopathology and genomic diagnostic laboratories.

Talk

Thu, Nov 12
10:45am–11:15am

Part of Clinically Actionable Mutational Signatures in Solid Tumors

Clinical Utility of Detecting Mismatch Repair Deficiency as a Mutational Signature

Finding mismatch repair deficiency as a mutational signature by sequencing, set against immunohistochemistry and PCR, and what it means for patients.

Ballroom E, Level 6, Arch at 705 Pike

Solid Tumors

Session

Sat, Nov 14
10:15am–11:45am

Current and Emerging Methods for Structural Variants and Gene Fusions

611-614, Level 6, Arch at 705 Pike

Hematopathology

10:15am–10:45amFISH vs. RNA sequencing for Structural Variant Detection in Solid Tumors: Strengths and LimitationsMayo Clinic
10:45am–11:15amImplementing Whole Transcriptome Sequencing for Fusion Detection in Solid Tumors: Lessons from the Clinical LaboratoryUniversity of Pittsburgh
11:15am–11:45amProximity Ligation Sequencing (Hi-C) for Oncogene Rearrangements in Lymphoid CancersUniversity of Michigan Medical School

Session

Sat, Nov 14
1:15pm–2:15pm

Platform Presentations of Selected HemePath Abstracts II

606-607, Level 6, Arch at 705 Pike

1:15pm–1:30pmH035 Concordance of Bone Marrow and Peripheral Blood Specimens for Fusion Gene Detection by RNA-Based Next-Generation Sequencing Using the Oncomine Myeloid Assay on the Ion Torrent Genexus PlatformUAB
1:30pm–1:45pmH065 MiSeq i100 Plus and OncoReveal Myeloid: Efficient NGS Detection of Actionable AML Variants, Including FLT3-ITDsAdvocate Clinical Laboratories
1:45pm–2:00pmH078 Clinical Significance of Clonal Hematopoiesis Detected by Paired Plasma and Peripheral Blood Liquid Biopsy Testing in Patients with Solid TumorsMD Anderson Cancer center
2:00pm–2:15pmH075 Assessing the Performance of a Novel All-Inclusive Duoseq NGS Assay in Multiple MyelomaIndiana University School of Medicine

Session

Sat, Nov 14
4:15pm–5:15pm

Hematopathology Plenary Session

611-614, Level 6, Arch at 705 Pike

4:15pm–5:15pmFrom Genome to Treatment: Tailoring Induction Chemotherapy for Acute Myeloid LeukemiaUniversity of Florida

Instantly find 20 buyers from Brigham and Women's Hospital

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with the Association for Molecular Pathology. Organization details are derived from AMP’s published lists. Submit a correction